Literatur
Dalela D et al. J Clin Oncol. 2017;35(18):1982–90.
Thompson IM et al. J Urol. 2009;181(3):956–62.
Bolla M et al. Lancet. 2012;380(9858):2018–27.
Wiegel T et al. J Clin Oncol. 2009;27(18):2924–30.
Kalbasi A et al. Cancer. 2014;120(19):3089–96.
Sineshaw HM et al. Eur Urol. 2015;68(5):768–74.
Spratt DE et al. J Clin Oncol. 2017;35(18):1991–8.
Den RB et al. J Clin Oncol. 2015;33(8):944–51.
Lughezzani G et al. Eur Urol. 2010;57(4):562–8.
Stish BJ et al. J Clin Oncol. 2016;34(32):3864–71.
Originalie
Dalela D et al. Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model. J Clin Oncol. 2017; 35(18):1982–90.
Author information
Authors and Affiliations
Corresponding author
Additional information
Erstpubliziert in Strahlenther Onkol. 2017;194(1):70-2.
Rights and permissions
About this article
Cite this article
Finazzi, T., Zimmermann, F. Genetischer Risikoscore noch nicht reif für die klinische Routine. Info Onkol. 21, 16–18 (2018). https://doi.org/10.1007/s15004-018-5950-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-018-5950-6